Effect of iron on renal tubular epithelial cells  by Sponsel, Heather T. et al.
Kidney International, Vol. 50 (1996), pp. 436—444
Effect of iron on renal tubular epithelial cells
HEATHER T. SPONSEL, ALLEN C. ALFREY, WILLIAM S. HAMMOND, JACQUES A. DURR, CARLA RAY,
and ROBERT J. ANDERSON
Departments of Medicine and Pathology, Denver Veterans Affairs Medical Center, University of Colorado Health Sciences Center, Denver, Colorado, and
Bay Pines Veterans Affairs Medical Center, University of South Florida, Tampa, Florida, USA
Effect of iron on renal tubular epithelial cells. Since iron has been
implicated as a potential nephrotoxin, we examined the effect of iron on
several aspects of cultured renal tubular epithelial cell biology. We found
that exposure to io M of either the ferrous or ferric form of iron
impaired healing of denuded areas made within confluent monolayers of
LLC-PK1 cells. This impairment required 30 to 80 hours of exposure to
iron to occur and was also seen in another renal tubular epithelial cell line
(MDCK cells). To delineate the potential mechanism(s) of this impair-
ment, we examined the expression of a key integrin subunit involved in
cell-matrix adhesion. Exposure of LLC-PK cells to iO M ferric citrate
for 72 hours significantly decreased expression of the 13 integrin subunit
as determined by flow cytometry. To determine if iron impairs another
process that occurs at the basolateral surface, the effects of 72 hours of
exposure to iron on adenylate cyclase activity were examined. Both ferric
and ferrous citrate significantly enhanced vasopressin- and forskolin-
stimulated adenylate cyclase activity. To examine if iron can regulate
proliferation, the effect of iron on 3H-thymidine uptake was measured. We
found that ferric citrate diminished proliferation and this decrease re-
quired the presence of either serum or transferrin. To ascertain if iron
affected ultrastructure, we used transmission electron microscopy and
found that iron accumulation within cells was much more apparent with
ferric than ferrous citrate. Ferric iron induced mild-to-moderate cyto-
pathic changes. These results indicate that iron is capable of inducing
multiple changes in renal tubular epithelial function. The effect of iron to
impair wound healing may be related to diminished expression of the f3
integrin subunit and perhaps to impaired proliferation.
There is considerable interest in a potential role for iron in the
pathogenesis of both acute and chronic renal injury. For example,
iron may be a pathogenetic factor in animals with acute renal
damage that occurs after exposure to hemoglobin, myoglobin and
puromycin [1, 2]. In in vitro studies with rat proximal tubule
segments, high concentrations of the ferrous form of iron exert
cytotoxic effects [3, 4]. Also, humans with either intravascular
hemolysis or transfusion hemosiderosis may experience proximal
tubular damage from iron [5, 6].
Most evidence for an injurious effect of iron on renal function
has been generated in the setting of either proteinuric states or
chronic renal insufficiency. In studies from our laboratory, human
proteinuric disorders as well as animal models of glomerulone-
phritis exhibit excess urinary iron excretion [7—10]. In these and
other animal models, an increase in renal cortical tissue iron is
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also present [7—12]. Others have recently found that iron accumu-
lation occurs in proximal tubular lysosomes in humans with
proteinuria and chronic renal failure [13]. Not only can increased
urinary and tissue iron be found in animal models of renal disease,
but also a variety of methods that reduce urinary iron excretion
decrease the rate of deterioration of renal function [7—9, 14—17].
Together, these results suggest that iron plays a pathogenetic role
in the progression of some forms of renal disease.
While there is accumulating evidence that iron can be nephro-
toxic, there is limited information on the pathophysiology of this
toxicity. The present studies were therefore designed to examine
the hypothesis that iron can exert adverse effects on renal tubular
epithelial cells. To test this hypothesis, the effects of in vitro
exposure to iron on several aspects of renal tubular epithelial cell
function were studied. Our results demonstrate that both ferrous
and ferric forms of iron can impair recovery of denuded areas
made within confluent monolayers of two renal tubular epithelial
cell lines. This effect of the ferric form of iron is associated with
decreased expression of the f3 integrin subunit and impaired
proliferation.
Methods
Materials
Ferric and ferrous citrate, transferrin and arginine vasopressin
were obtained from Sigma. Forskolin was obtained from Calbio-
chem. A monoclonal antibody against the extracellular domain of
the 13 integrin subunit was obtained from Chemicon. Cellititer 96
AQeous Non-Radioactive Cell Proliferation Assay kits were
obtained from Promega. 3H-thymidine (70 to 85 Ci/mmol) was
obtained from Amersham. a-32P adenosine triphosphate (ATP)
(30 to 40 Ci/mmol) was obtained from Du Pont-New England
Nuclear.
Cell and culture conditions
LLC-PK1 and MDCK cells were obtained from the American
Type Culture Collection and were studied after 70 to 90 passes.
Most studies were done with LLC-PK1 studies since we have
extensive experience with this cell type [18—20]. Moreover, pre-
liminary studies using flow cytometry and a variety of cell surface
markers demonstrated that our MDCK line contained a hetero-
geneous population of cells. Membranes for adenylate cyclase
assays were obtained from cells grown on 85-cm2 plastic flasks and
wound healing studies were done on cells grown on 60-mm dishes
(Falcon). LLC-PK1 cells were grown in RPMI 1640 medium
(Irvine Scientific) and MDCK cells were grown in minimal
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essential medium (MEM). Both media were supplemented with
200 mg/100 ml sodium bicarbonate, 16 mri N-2-hydroxyeth-
ylpiperazine-N-2-ethanesuifuronic acid (HEPES), 100 U/mi pen-
icillin, and 200 xg/ml streptomycin. Newborn calf serum (6%) was
added to the media for the initial 3 to 7 days of growth while
monolayer proliferation was established, after which all cultures
received serum-free media. Serum-free conditions were used for
48 hours prior to each experiment. The cultures were maintained
at 37°C in a humidified atmosphere of 95% air-5% CO2. Cell
growth was monitored under an inverted microscope with phase
optics (Nikon 1M35) and typically reached confluence in five to
seven days. Confluent cultures were selected for biochemical
studies.
Wound preparation and assessment
A sterile, fine-tipped needle was used to make two to six
wounds near the center of each confluent monolayer as described
previously [18, 19]. Two strips of cells were gently removed. One
strip was horizontal while the other was vertical and bisected the
middle of the horizontal strip resulting in a cross-shaped wound.
The area of the rectangle formed where the two perpendicular
strips of removed cells intersected was measured at the time of
wound creation and six hours later. The surface area of this wound
averaged 0.04 mm2. Wound healing was quantitated by observa-
tion and measurement at lOx to 20x power using an inverted
microscope with phase optics (Nikon 1M35) and an eyepiece
reticle. In preliminary studies, time lapse photography and con-
tinuous video microscopy of wound healing were also done.
Analysis of photographs confirmed eyepiece measurements of
wound healing. We have previously demonstrated little intra-
observer variation in wound measurements and a high degree of
inter-observer concordance of wound measurements [18]. In all of
the present experiments, wounds were measured by a single
observer who was unaware of the treatment conditions. When test
agents were used, they were added immediately after wound
creation and maintained throughout the period of observation.
Although cells were exposed to either ferrous or ferric citrate, we
cannot be certain that pure concentrations of these ions were used
since it is possible that oxidation/reduction reactions occurred
during the experiment. In experiments in which iron and trans-
ferrin were both used, each agent was given separately at the
indicated concentration. No effort was made to ascertain the
relative abundance of "free" and protein-bound" iron in experi-
ments where iron and either transferrin or serum were used
concomitantly.
Crude membrane preparation
Confluent cultures were washed three times with 8 ml of cold
phosphate-buffered saline (PBS) containing 0.9 mvi CaCl2 and 0.5
mM MgCl2, and the cells were harvested by scraping three times
with 4 ml of ice-cold EDTA (1 mM)-tris(hydroxymethyl)ami-
nomethane (Tris, 50 mM) buffer (pH 7.4). Membranes were
homogenized with 15 strokes of Dounce homogenizer, centri-
fuged at 14,000 revolutions/mm at 4°C for five minutes, and
resuspended in 500 tl of EDTA-Tris buffer.
Adenylate cyclase assay
Adenylate cyclase activity was measured using slight modifica-
tions of previously described techniques and carried out in a final
volume of 50 pd [20]. Ten microliters of membrane preparation
(-10 xg of protein) were added to an assay mixture containing (in
mM) 0.25 Na-EDTA, 5.25 MgC12, 1.0 cAMP, and 1.0 purified
[s-32]ATP 2 X 106 counts/mm) in 25 Tris-HC1 (pH 7.4) and an
ATP-regenerating system consisting of 20 mrvt creatinine phos-
phate and 100 lU/mi creatinine phosphokinase. After a 10-minute
incubation at 30°C, the reaction was stopped by adding 150 tl of
ice-cold stopping solution containing in (mM) 3.3 ATP, 4 cAMP,
and 40 Tris-HC1, as well as 10,000 to 15,000 counts/mm of
[3H]cAMP for recovery, which averaged 50 to 70%. [32P]ATP was
separated from unreacted [a-32IATP by a sequential two-step
elution over Dowex and alumina columns. Assays were carried out
in triplicate with an SE of the mean usually less than 2 to 3%.
Assessment of proliferation
Two methods were used. [3H-thymidine uptake studies were
performed in 24-well panels in which LLC-PK1 cells were grown
to -70 to 80% confluency. After exposure to various effectors in
6% newborn calf serum, medium was replaced with fresh medium
containing [methyl-3H]-thymidine (70 to 85 Ci/mmol, 5 ml/ml
medium) for four hours. Monolayers were then washed three
times with cold PBS and three times with cold 5% TCA, and then
cells were solubilized in equal parts 0.25 N NaOH and 0.1% SDS.
Radioactivity was determined by liquid scintillation counting. For
each experiment, three to four wells were studied under each
experimental condition and the three to four results were aver-
aged to obtain an N value of 1 for that condition. Each experiment
was typically repeated on three to five occasions.
A second method used a Ceiltiter 96 AQueous Non-Radioac-
tive Cell Proliferation Assay kit. This method was used to confirm
and extend our 3H-thymidine uptake studies. In this assay, a
tetrazolium compound is converted into an aqueous soluble
formazan by dehydrogenase enzymes present in metabolically
active cells. The amount of formazan produced as measured by
the amount of 490 nM absorbance on an ELISA plate reader is
directly proportioned to the number of living cells in the culture.
This method correlates closely with 3H-thymidine results. In these
studies, LLC-PK1 cells were grown on a 96-well microtiter plate
and the process carried out exactly as instructed. All experiments
were done in triplicate and each experiment repeated four to six
times.
Flow cytomet!y studies
LLC-PK1 cells for flow cytometry studies were plated at a
density of 106 cells/100 mm dish in RPMI with 6% newborn calf
serum. Cells were washed three times with PBS, trypsinized with
0.5 ml/plate of 0.05% trypsin/0.02% EDTA for two minutes at
room temperature. The trypsin was neutralized with 1 mi/plate of
0.5% soybean trypsin inhibitor for two minutes at room temper-
ature. The plates were rinsed with an additional 2 to 3 mi/plate
with trypsin inhibitor and the cell suspension pelleted at 650 X g
for five minutes at 4°C. The cells were then washed twice with
MEM containing 0.1% BSA and 25 mm HEPES. Cells were then
incubated in the same solution for ten minutes at 37°C. The cells
were washed three times with PBS, counted and incubated with a
1:50 solution of a monoclonal antibody directed against /3
integrin subunit for 60 minutes at 4°C. The cells were washed
three times with PBS then incubated with a fluorescein conjugated
Fab fragment goat anti-mouse immunoglobulin (gamma and light
chains, Biosource International) at a 1:100 dilution for 60 minutes
at 4°C. The cells were washed three times with PBS and analyzed.
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The expression of f3 was determined with a Coulter XL-MCL
flow cytometer (Coulter Electronics) with an argon ion laser
turned to 488 nm and operated at 15 mW. Forward light scatter
was collected through a BP 488/20 band pass filter and nonviable
cells were electronically gated out. Fluorescence data were lin-
early amplified, collected and analyzed in list mode using Coulter
XL-MCL software. Data were calculated as with either percent
positive of the cell population or as relative fluorescence index
(RI). The RI was calculated as mean sample fluorescence/mean
control fluorescence.
Electron microscopic studies
Cells were fixed in situ by flooding their tissue culture dishes
with 2% glutaraldehyde in cacodylate buffer. They were dehy-
drated in situ and embedded by inverting "00" plastic capsules
filled with Mollenhauer's embedding mixture over the monolay-
ers. Following polymerization, the capsule with the attached
monolayer and portion of culture dish was bisected. A small
portion including the monolayer was mounted on an epoxy block
oriented so that the monolayer could be cut at right angles.
Subsequently, ultramicrotomy, staining and electron microscopy
were performed using standard techniques.
Protein assay
Protein was estimated by a modified method of Bradford
(Bio-Rad) using bovine serum albumin as a standard [211.
Statistical analyses
All calculations were performed on an AT&T desk top com-
puter using INSTAT software. Statistical analysis was paired and
unpaired Student's i-tests and analysis of variance where appro-
priate. All experiments were typically performed on four to eight
occasions and mean values SEM are given.
Results
Preliminary dosing studies were undertaken to determine con-
centrations of iron to study. Initially, we examined the effect of
exposure of LLC-PK1 and MDCK cells to 10—6 through 10_2 M of
ferric and ferrous citrate for 2 to 72 hours. Exposure to 10_2 M
and io M concentrations of either ferric or ferrous citrate for
two hours or longer resulted in a generalized stippled appearance
of all cells, irregular loss of cell attachment and significant uptake
of trypan blue. These effects were pronounced at 102 M and less
marked at iO M. At 10 M, we were not able to ascertain any
difference between control cells and iron-treated cells for up to 96
hours of exposure. For the experiments repeated herein, a iO M
concentration of ferric and ferrous citrate was used. Based upon
our previous in vivo studies, we feel this concentration of iron can
be seen in urine in proteinuric states [7—10].
We first determined the effect of varying times of exposure to
ferrous citrate (10—a M) on healing of denuded areas made within
LLC-PK1 cell monolayers (Fig. 1A). In these studies, (N = 6 to 8
in each group), exposure to ferrous citrate at the time of wound
creation did not significantly affect the degree of healing. How-
ever, exposure to ferrous citrate for 24 and 72 hours prior to
wound creation with continuing exposure during the six hours of
assessment of healing significantly impaired the recovery process.
To determine if these effects occur in another renal tubular
epithelial cell line, similar experiments were done in MDCK cells
(Fig. 1B). Prolonged (78 hr) but 30 hours or less exposure to
ferrous citrate moderately impaired recovery of MDCK cells.
Since high concentrations (4 X I o M) of ferrous forms of iron
have been clearly demonstrated to induce oxidant injury to
isolated rat proximal tubular cell suspensions [3, 4, 22], we
examined the effect of iO M of the ferric citrate form of iron on
healing of denuded areas made in LLC-PK1 and MDCK cell
monolayers (Fig. 2). In these studies, ferric citrate produced a
modest but significant impairment in LLC-PK1 recovery and did
not significantly affect MDCK recovery.
Recovering of denuded areas made within a confluent mono-
layer could occur by either cellular proliferation or migration.
Previously, we have provided evidence supporting a role for
migration as at least partially responsible for the recovery process
[18, 19]. Since cell adhesion is necessary for migration, we next
examined the effect of 72 hours' exposure to ferric citrate on
LLC-PK1 expression of a key cell-matrix integrin subunit (13k)
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Fig. 1. Effect of 6, 30 and 78 hours' exposure to ferrous citrate on healing of
denuded areas made within LLC-PK1 (A, LI) and MDCK cell monolayers (B,). Each bar represents the mean SEM of 6 to 8 studies. The * < 0.05
when compared with control (no iron exposure).
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Fig. 2. Effect of 6, 30 and 78 hours' exposure to fenic citrate on healing of
denuded areas made within LLC-PK1 (A, LI) and MDCK cell monolayers (B,). Each bar represents the mean SEM of 6 to 8 studies. *p < 0.05 when
compared with control (no iron exposure).
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Fig. 3. Effect of i0' Mfernc citrate for 72 hours on expression of integrin
in LLC-PKJ cells. The lines connect paired experiments. The data are
expressed as relative index (mean sample fluorescence/mean control
fluorescence). The P value by paired analysis is < 0.05.
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Fig. 4. Effect of ferric (A) and ferrous •) citrate on arginine vasopressin-
stimulated adenylate cyclase activity. Each data point represents the
mean SCM of 4 paired experiments carried Out in triplicate. Each control
value (S) for arginine vasopressin-stimulated adenylate cyclase activity is
significantly (P < 0.05) less in the absence than in the presence of either
form of iron.
important in cell adhesion and migration [18, 19, 22—24]. In these
paired flow cytometric studies, exposure to iO M ferric citrate
for 72 hours produced a modest but consistent significant de-
crease in LLC-PK1 J3 integrin expression (Fig. 3). In these
0
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Fig. 5. Effect of ferric (A) and ferrous (•) citrate on forskolin-stimulated
adenylate cyclase activity. Each data point represents that mean SEM of
4 paired experiments done in triplicate. Each control value (•) for
forskolin-stimulated adenylate cyclase activity is significantly (P < 0.05)
less in the absence than in the presence of either form of iron.
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Fig. 6. Effect of transferrin (30 ng/ml) on 3H-thymidine uptake in LLC-PK1
cells exposed for 72 hours to either ferrous citrate (left) orferric citrate (right).
Each bar represents the mean SCM of 4 determinations done in
duplicate. Symbols are: (LI) —transferrin; () +transferrin; *p < 0.05.
studies, ferric citrate decreased the % LLC-PK1 cells positive for
the f3 integrin subunit from > 90 to 60 5% (P < 0.01).
The 13 integrin subunit studies suggest the potential for iron to
impair at least one aspect of renal tubular epithelial cell function
that occurs at the basolateral cell surface. We therefore examined
if another basolateral function (activation of hormone-responsive
adenylate cyclase) was affected by iron exposure. In these paired
studies, both iO M ferric and ferrous citrate significantly poten-
tiated both arginine vasopressin- and forskolin-stimulated adenyl-
ate cyclase activity (Figs. 4 and 5).
We next examined the effect of 72 hours of iron on LLC-PK1
cell proliferation. In preliminary studies, we found that the effects
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Fig. 8. Monolayer (x27,000) grown with ferrous citrate. There are a slightly swollen mitochondrion (M) and a few lysosomes (L) containing myelin-like
figures. Ultrastructure is otherwise well preserved.
of iron on 3H-thymidine uptake appeared to be dependent on the
presence or absence of serum and on the species of iron studied.
Specifically, ferric citrate appeared to decrease 3H-thymidine
uptake only in the presence of 6% newborn calf serum while
ferrous citrate minimally affected uptake in either the absence or
presence of serum. We reasoned that one component of serum
that could explain these results is transferrin, which potentially
mediates cell uptake of ferric iron. To study this issue, the effect
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Fig. 7. Dose-response effect of transferrin on
control (no iron, E) and ferrous citrate- ) and
ferric citrate-treated () (1O Mfor 72 hr) LLC-
PK1 cells on proliferation as assessed by formazan
production. Each bar represents the mean
SEM of 5 measurements done in triplicate.
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Fig. 9. Monolayer (x27,000) grown with ferric citrate. Numerous lysosomes (some indicated by L) containing iron particles are present. Numerous
intermediate filaments (F) occupy much of the cytoplasm in this field.
of 72 hours of exposure to l0 M ferrous and ferric forms of iron
on 3H-thymidine uptake were examined in LLC-PK1 cells. In
control cells that were not exposed to iron (not shown in Fig. 6),
3H-thymidine uptake averaged 13,640 2,200 cpm. Neither
ferrous nor ferric citrate affected 3H-thymidine uptake in the
absence of transferrin. Ferric but not ferrous iron modestly
impaired 3H-thymidine uptake in the presence of transferrin.
To study this phenomenon in more detail, we examined the
effect of 72 hours of exposure to either ferrous or ferric citrate on
proliferation in serum-free media in the absence or presence of
varying concentrations of transferrin (Fig. 7). In control cells,
transferrin exerted a dose-dependent effect to increase formazan
production. Such an effect was not observed in ferrous citrate-
treated cells. A dose-dependent effect of transferrin to inhibit
formazan production is seen in the presence of iO M ferric
citrate. Together, these results suggest that i0 M ferric iron, in
the presence of transferrin, can inhibit LLC-PK1 cell prolifera-
tion.
To confirm and extend these studies, cell morphology was
examined by transmission electron microscopy (Figs. 8 to 10).
Monolayers used in these studies were grown in the presence of
6% serum. Cells grown in ferrous citrate and control cells contain
little iron identifiable by electron microscopy. They have essen-
tially normal ultrastructural morphology (Fig. 8). In contrast, cells
grown with ferric citrate in the medium contain large amounts of
iron in lysosomes (Fig. 9). Ferric citrate treated cells display
evidence of cell injury, including lucency of cytosol, dilation of
profiles of endoplasmic reticulum, distortion of mitochondrial
profiles, increase in intermediate filaments, and the presence of
autophagosomes containing myelin-like Figures (Fig. 10). How-
ever, the junctional complexes separating the "lumenal" surfaces
from the basolateral spaces are intact (Fig. 10).
Discussion
Substantial evidence suggests that the transition element iron
can be nephrotoxic [1—17]. Zager et al have provided evidence
that high concentrations of the ferrous form of iron exert acute
cytotoxicity in rat renal proximal tubular segments [3, 4, 22]. Our
and other investigators' interest in a potential nephrotoxic role for
iron has predominantly centered on an effect of iron to cause
progressive functional deterioration in a diseased kidney [7—12,
141. It is well-known that functional renal deterioration correlates
more closely with the extent of tubulointerstitial injury than
glomerular pathology in both humans and in animal models of
glomerular disorders [7, 26]. A close association between tubulo-
interstitial disease and proteinuria has been established [26].
However, the mechanisms suggested for proteinuria per se to
induce tubulointerstitial disease are not convincing, suggesting
that perhaps something accompanying the proteinuria is the
injurious agent [27, 28]. Iron is presented to renal tubular
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Fig. 10. Detail of monolayer cell (X 74,000) grown with ferric citrate, An apparently disrupted lysosome (L) contains particulate iron and myelin-like
figures. Dilated profiles of rough endoplasmic reticulum (ER), a swollen mitochondrion (M), and a second lysosome containing myelin-Iike figures are
also present.
epithelial cells in proteinuric states due to glomerular leak of
transferrin [7—10]. Based upon several studies, we have previously
postulated, but not directly confirmed, that the low pH and
bicarbonate content of renal tubular fluid would dissociate iron
from transferrin and cause iron to exist in a reactive form capable
of catalyzing hydroxy radical formation [7—10]. The present in vitro
studies were designed to more closely examine the effects of
"apically applied" iron on renal tubular epithelial cell function.
Our results demonstrate several effects of both ferric and ferrous
forms of iron on the structure and function of two established
renal tubular epithelial cell lines.
Initially, we examined the effect of iron on the process whereby
LLC-PK1 and MDCK cell monolayers re-established areas of
denuded cells. We examined this function since re-establishment
of an intact epithelium potentially plays an important role in
recovery from renal injury. We found that ferrous citrate modestly
impaired re-establishment of mechanically denuded areas in both
LLC-PK1 and MDCK cells and that 30 to 78 hours of exposure to
ferrous citrate was required for this impairment. Since ferrous
citrate has been documented to induce oxidant stress and renal
tubular cytotoxicity [3, 4, 22], we also examined the effect of ferric
citrate on healing of denuded areas. A 78 hour exposure to ferric
citrate also modestly impaired healing of LLC-PK1, but not
MDCK monolayer wounds.
The exact mechanism whereby cells re-establish denuded areas
remains unknown, although changes in cell shape, cell migration
and cell proliferation could all potentially contribute to the
healing process [29]. Integrins are transmembrane glycoprotein
heterodimers felt to be important in cell-matrix attachment and
potentially serve a role in determining cell shape, motility and
proliferation [23, 24, 291. We therefore used flow cytometxy to
examine the effect of 78 hours of exposure to ferric citrate on
expression of the I3 integrin subunit. We selected the /3 integrin
subunit since it is expressed in nearly 100% of LLC-PK1 cells and
is the major /3 integrin subunit felt to be functionally significant
in epithelial cells [23, 24]. We found that exposure to ferric citrate
resulted in a modest, significant decrease in I3 expression. The
effect of ferric citrate to impair recovery and to diminish expres-
sion of 13 integrin were comparable at 20 to 25%. Together, the
results suggest that the effect of ferric iron to attenuate LLC-PK1
recovery from mechanical injury could be due to decreased f3
integrin expression. Additional studies are clearly needed to
further test this hypothesis.
Since integrins are found predominantly on the basolateral cell
surface, we also examined the effect of iron exposure on another
cell function that occurs at the basolateral surface. In these
studies, we found that both ferrous and ferric forms of iron
enhanced adenylate cyclase activity stimulated both by a hormone
(arginine vasopressin) and a direct activator of the catalytic
subunit (forskolin). The effect of ferric and ferrous forms of iron
Sponsel et a!: Iron and renal tubular cell toxicity 443
to promote adenylate cyclase activity was seen only for agonist-
stimulated activity and not at the basal level. In the studies that
were performed, we did not measure the cAMP production rate
(velocity) versus substrate concentration (MgATP) but rather the
velocity versus the concentration of an agonist. The relationship
that we measured can be analyzed, however, in terms of Michaelis
Menton kinetics [30]. Such an analysis does not give a traditional
Km (that is, the substrate concentration at which one has 1/2
Vmax) but a Ka (the agonist concentration at which one observes
1/2 maximal activation of the responsive enzyme). When Michae-
lis Menton kinetics are applied to our results, ferric iron reduces
the Ka for AVP stimulation and reduces 1/V,,,ax. This pattern is
compatible with "nonessential activation" of adenylate cyclase by
iron [30]. Although further studies are needed to clarify the effect
of iron to promote adenylate cyclase activity, our results suggest
that perhaps the effect of iron to decrease 13 integrin expression
and wound healing is not simply a nonspecific toxic effect exerted
at the basolateral membrane.
In the presence of transferrin in increasing concentrations, we
also found that ferric iron significantly decreased proliferation as
determined by both formazan production and 3H-thymidine up-
take in LLC-PK1 cells. It should be noted that the assays we used
for proliferation are indirect and could potentially be affected by
cell injury. Thus, conclusions regarding the effect of ferric iron on
proliferation require confirmation by quantification of cell num-
ber. The decrease in thymidine uptake and formazan production
that we observed was associated with increased cellular uptake of
iron and evidence of microscopic injury as demonstrated by
lucency of cytosol, dilation of profiles of endoplasmic reticulum,
distortion of mitochondrial profile and increase in intermediate
filaments. Phospholipidosis was also present [31]. In contrast,
neither ferrous nor ferric citrate, in the absence of transferrin,
effect LLC-PK1 cell proliferation as determined by formazan
production or 3H-thymidine uptake. In addition, there was little
cellular uptake of iron and histological evidence of cellular injury
from either of these compounds alone. Even in the presence of
transferrin, ferrous citrate had no effect on proliferation, and little
effect on cellular iron uptake and histological evidence of toxicity.
Since ferrous iron, in contrast to ferric iron, binds weakly, if at all,
to transferrin, this is consistent with cellular uptake of iron being
limited to transferrin-bound iron, as we found by transmission
electron microscopy. The uptake of transferrin-iron complex is
presumably, at least in part, via transferrin receptors present on
LLC-PK1 cells. From the present study it cannot be determined
whether iron uptake was primarily mediated from the basolateral
or apical surface of LLC-PK1 cells. Transferrin receptors are
present on the basolateral surface of renal tubular epithelial cells
[33, 34]. In addition, it has been well documented that transferrin-
iron complex is readily taken up by proximal tubule cells from
tubule fluid in the nephrotic syndrome by endocytosis [12].
The mechanism whereby iron impairs wound recovery and
inhibits proliferation was not addressed in our studies. Other
studies have shown that intracellular generation of iron-depen-
dent radical causes oxidant injury in LLC-PK1 cells as well as
other cell lines [22, 37] and LLC-PK1 cells are more susceptible to
oxidant injury than MDCK cells [36]. The finding that MDCK
cells were less prone to iron-induced alterations than LLC-PK1
cells are consistent with iron-induced oxidant injury in the current
study. The fact that neither cellular uptake of iron nor transferrin
was required for iron to effect wound healing and diminish
expression of f3 integrin expression suggests that even free tubule
fluid iron could have a detrimental effect in proteinuric states.
In summary, the present studies indicate that iron is capable of
affecting several aspects of cultured renal tubular epithelial cell
function. The precise effects of iron are dependent upon dose,
duration of exposure, molecular species and the presence or
absence of iron transporting proteins. Our results are compatible
with the notion that renal tubular iron is a potentially important
contributing factor in both acute renal tubular cell injury and in
the renal tubulointerstitial injury that can occur in proteinuric
disorders.
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